Freed
+500%
est. 2Y upside i
Meet Freed: The AI assistant loved by 20,000+ happy clinicians. Freed listens, transcribes, and creates comprehensive SOAP notes faster than you can say "documentation backlog."
Rank
#2
Sector
Healthtech
Est. Liquidity
~2Y
Data Quality
Data: LowThe math suggests enormous equity upside because the $37M entry valuation is only ~1.9x current ARR, and even bear-case scenarios exit far above that.
Last updated: August 21, 2026
If Freed reaches category leadership and IPO window opens, it could command 12x forward revenue, implying a $2.1B exit (raw +5,520%). After 20% dilution and Series A bull cap, upside is +400%.
Revenue grows to $175M by month 24; at 8x forward revenue the exit value is $1.4B, ~37x entry. After 20% dilution, net upside is +3,627%.
Even with multiple compression to 3x and competitive pressure, exit value is $524M, ~14x entry. After 20% dilution, upside is +1,285%; the $34M preference overhang is immaterial at this exit size.
Preference Stack Risk
severeFunding Intensity
91%Total funding of $34M is 91% of the $37.3M valuation, so 1x preferred leaves little residual value for common in a down round.
Dilution Risk
highSeries A was ~17 months ago; with aggressive growth, a Series B raise will likely dilute current holders by ~20%.
Secondary Liquidity
noneNo secondary market signals exist; employee shares are illiquid until an exit.
Engineering — 6 roles
- Fullstack AI Engineer · San Francisco
- ML Engineer, Voice & AI · San Francisco
- Principal Software Engineer · San Francisco
- +3 more →
Marketing — 3 roles
- Field Marketing · New York
- Marketing Data and Analytics · New York
- Offline Marketing · San Francisco
Customer Success — 1 role
- Clinician Support Representative · New York
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Freed's data — designed to show you've done your homework.
- 1
“How does Freed plan to counter Doximity's free AI scribe without eroding its subscription revenue?”
- 2
“What is net revenue retention across the $39-$119 tier mix, and how does the $20M ARR break down by segment?”
- 3
“Given the current $37M valuation and $34M total funding, what is the post-money ownership structure and how would a Series B affect employee equity?”
Community
Valuation Sentiment
Our model estimates +500% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.